Lmr Partners LLP Curis Inc Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$7.45 - $16.27 $410,651 - $896,818
-55,121 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$8.78 - $12.8 $483,962 - $705,548
55,121 New
55,121 $624,000
Q3 2018

Nov 14, 2018
SELL
$1.38 - $1.94 $98,625 - $138,647
-71,468 Closed
0 $0
Q2 2018

Aug 03, 2018
BUY
$1.73 - $3.35 $123,639 - $239,417
71,468 New
71,468 $124,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $403M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email